BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11271788)

  • 1. Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Pukkila MJ; Virtaniemi JA; Kumpulainen EJ; Pirinen RT; Johansson RT; Valtonen HJ; Juhola MT; Kosma VM
    J Clin Pathol; 2001 Jan; 54(1):42-7. PubMed ID: 11271788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
    Pirinen RT; Hirvikoski P; Johansson RT; Hollmén S; Kosma VM
    J Clin Pathol; 2001 May; 54(5):391-5. PubMed ID: 11328840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: prognostic implications.
    Pukkila MJ; Kumpulainen EJ; Virtaniemi JA; Johansson RT; Halonen PM; Kellokoski JK; Kosunen AS; Nuutinen J; Kosma VM
    Head Neck; 2002 Aug; 24(8):784-91. PubMed ID: 12203805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.
    Lin YC; Wu MY; Li DR; Wu XY; Zheng RM
    World J Gastroenterol; 2004 Nov; 10(22):3235-9. PubMed ID: 15484291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
    Bagutti C; Speight PM; Watt FM
    J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of E-cadherin and β-catenin expression in HPV-negative oropharyngeal squamous cell carcinomas.
    García-Pedrero JM; García-Cabo P; Ángeles Villaronga M; Hermida-Prado F; Granda-Díaz R; Allonca E; Rodrigo JP
    Head Neck; 2017 Nov; 39(11):2293-2300. PubMed ID: 28815780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.
    Gong Z; Hu G
    Cancer Biomark; 2019; 26(2):209-217. PubMed ID: 31450490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer.
    Chien CY; Huang CC; Cheng JT; Chen CM; Hwang CF; Su CY
    Cancer Lett; 2003 Nov; 201(2):217-23. PubMed ID: 14607337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
    Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
    Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava EM; Kosma VM
    J Clin Pathol; 1999 Jan; 52(1):10-6. PubMed ID: 10343606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of alpha-, beta-, and gamma-catenins indifferentiated thyroid carcinoma.
    Böhm J; Niskanen L; Kiraly K; Kellokoski J; Eskelinen M; Hollmen S; Alhava E; Kosma VM
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4806-11. PubMed ID: 11134147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival.
    Pukkila MJ; Kellokoski JK; Virtaniemi JA; Kumpulainen EJ; Johansson RT; Halonen PM; Kosunen AS; Nuutinen J; Kosma VM
    Laryngoscope; 2002 Jun; 112(6):1084-8. PubMed ID: 12160278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Catenin Alterations in Squamous Cell Carcinoma of the Lip.
    Barakat C
    Asian Pac J Cancer Prev; 2015; 16(13):5187-90. PubMed ID: 26225651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
    Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
    Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
    Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
    J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer.
    Birtalan E; Danos K; Gurbi B; Brauswetter D; Halasz J; Kalocsane Piurko V; Acs B; Antal B; Mihalyi R; Pato A; Fent Z; Polony G; Timar J; Tamas L
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):e79-e85. PubMed ID: 29271789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.